TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32026844

Group type: EXPERIMENTAL
Intervention: Virtual Reality Rehabilitation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional Rehabilitation
Number of subjects: 51
Study: 35044989

Group type: EXPERIMENTAL
Intervention: Peer-led online community
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control group (no peer leaders)
Number of subjects: 900
Study: 32895332

Group type: EXPERIMENTAL
Intervention: Single-use duodenoscope
Number of subjects: 98

Group type: COMPARATOR
Intervention: Reusable duodenoscope
Number of subjects: 98
Study: 32513581

Group type: EXPERIMENTAL
Intervention: 100 mg soy isoflavone daily for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 36476258

Group type: EXPERIMENTAL
Intervention: Typhoid Vi-polysaccharide conjugate vaccine (Typbar-TCV®) and measles vaccine (MV) concomitantly at 9 months (Group 1)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Typhoid Vi-polysaccharide conjugate vaccine (Typbar-TCV®) and measles vaccine (MV) on Day 0 and Day 28 (Group 2)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Typhoid Vi-polysaccharide conjugate vaccine (Typbar-TCV®) at 8 months and MV 28 days later (Group 3)
Number of subjects: 493

Group type: COMPARATOR
Intervention: Measles vaccine only at 9 months (Group 4)
Number of subjects: 493
Study: 33511671

Group type: EXPERIMENTAL
Intervention: Mental simulation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32559353

Group type: EXPERIMENTAL
Intervention: PSMA radioligand therapy (RLT) with 177Lu (Lu-PSMA)
Number of subjects: 0
Study: 36326742

Group type: EXPERIMENTAL
Intervention: Modified uvulopalatopharyngoplasty (mUPPP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Tonsillectomy (TE)
Number of subjects: 93
Study: 33402209

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation
Number of subjects: 850

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 850
Study: 36057025

Group type: EXPERIMENTAL
Intervention: Brief Group Intervention (BGI) using the FRAMES model
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control Group (CG) standard service
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Brief Group Intervention (BGI)
Number of subjects: 112
Study: 33745724

Group type: EXPERIMENTAL
Intervention: Prolonged infertility (≥60 months)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Extended TTP (≥36 months)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Fertile controls (0 months)
Number of subjects: 104
Study: 35016670

Group type: EXPERIMENTAL
Intervention: Dignity Therapy
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Interrater reliability assessment
Number of subjects: 46
Study: 35382793

Group type: EXPERIMENTAL
Intervention: PLAYshop intervention (75-min in-person workshop, educational materials, equipment pack, two post-workshop booster emails)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 143
Study: 32830894

Group type: EXPERIMENTAL
Intervention: Canakinumab 300 mg IV
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Canakinumab 600 mg IV
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 35642699

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 16
Study: 34625562

Group type: EXPERIMENTAL
Intervention: Completion axillary lymph node dissection (cALND)
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy (SLNB) alone
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC) after ALND
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (AC) before ALND
Number of subjects: 1855
Study: 36423444

Group type: COMPARATOR
Intervention: No preparation
Number of subjects: 161

Group type: COMPARATOR
Intervention: Oral antibiotic bowel preparation (OABP)
Number of subjects: 161

Group type: COMPARATOR
Intervention: OABP plus mechanical bowel preparation (MBP)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: OABP
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: OABP+MBP
Number of subjects: 161
Study: 34338231

Group type: EXPERIMENTAL
Intervention: Doxycycline added to standard antituberculous therapy (ATT) for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo added to standard antituberculous therapy (ATT)
Number of subjects: 0
Study: 32827483

Group type: EXPERIMENTAL
Intervention: Oral metronomic chemotherapy (15 mg/m2 methotrexate once per week plus 200 mg celecoxib twice per day until disease progression or intolerable side effects)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Intravenous cisplatin (75 mg/m2 once every 3 weeks for six cycles)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Oral metronomic chemotherapy
Number of subjects: 422

Group type: COMPARATOR
Intervention: Intravenous cisplatin
Number of subjects: 422
Study: 33684325

Group type: EXPERIMENTAL
Intervention: Yoga intervention (20, 75-min, in-person, group, gentle yoga classes held twice weekly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study: 35368921

Group type: EXPERIMENTAL
Intervention: syndrome-position point selection method (acupuncture at corresponding acupoints)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: syndrome-position point selection method
Number of subjects: 100

Group type: COMPARATOR
Intervention: traditional acupuncture method
Number of subjects: 100
Study: 34151602

Group type: EXPERIMENTAL
Intervention: Interactive virtual reality treatment over ten sessions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Interactive virtual reality treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 6
Study: 32162103

Group type: EXPERIMENTAL
Intervention: THC (low dose)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 71
Study: 35477628

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine ODF 180 mcg
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine ODF 120 mcg
Number of subjects: 760

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine ODF (both doses)
Number of subjects: 760
Study: 32937627

Group type: EXPERIMENTAL
Intervention: Intravesical administration of melatonin (25 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rectal administration of melatonin (25 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Transdermal administration of melatonin (25 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vaginal administration of melatonin (25 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous administration of melatonin (25 mg)
Number of subjects: 10
Study: 35414560

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34288578

Group type: EXPERIMENTAL
Intervention: Avanafil (200 mg) under fasting conditions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Avanafil (200 mg) under fed conditions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Avanafil (200 mg)
Number of subjects: 100
Study: 35437959

Group type: EXPERIMENTAL
Intervention: Coated Foley catheter (case group)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional non-coated Foley catheter (control group)
Number of subjects: 85
Study: 33597336

Group type: EXPERIMENTAL
Intervention: Systemic administration of vitamin C (600 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of local and systemic administration of vitamin C (600 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no vitamin C administration)
Number of subjects: 30
Study: 35417075

Group type: EXPERIMENTAL
Intervention: Psycho-education for parents
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Teaching parents/teachers to use negative consequences
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Individual training
Number of subjects: 2594
Study: 32299106

Group type: EXPERIMENTAL
Intervention: Amniotomy at 6 to <8 hours after oxytocin
Number of subjects: 2854

Group type: EXPERIMENTAL
Intervention: Amniotomy at time intervals ≥4 hours after oxytocin
Number of subjects: 2854

Group type: EXPERIMENTAL
Intervention: Amniotomy at time intervals ≥2 hours and <8 hours after oxytocin
Number of subjects: 2854

Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 2854

Group type: COMPARATOR
Intervention: No amniotomy
Number of subjects: 2854
Study: 33207670

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) program as a complementary tool to conventional cardiac rehabilitation (CR) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment group (Control Group)
Number of subjects: 0
Study: 34560141

Group type: EXPERIMENTAL
Intervention: Opponent tended to be competitive (cooperative 20% of the time)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Opponent tended to be cooperative (cooperative 80% of the time)
Number of subjects: 0
Study: 32595244

Group type: EXPERIMENTAL
Intervention: WS 1442 2x450 mg/day (WS-standard)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: WS 1442 2x900 mg/day (WS-double)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise 2x30 minutes/week (NW-low)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise 4x45 minutes/week (NW-high)
Number of subjects: 60
Study: 34965338

Group type: EXPERIMENTAL
Intervention: Dolutegravir-based ART
Number of subjects: 707

Group type: COMPARATOR
Intervention: Standard care (non-dolutegravir-based ART)
Number of subjects: 707
Study: 32190684

Group type: EXPERIMENTAL
Intervention: Auricular vagus nerve stimulation and 20 sessions of a home‐based exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Home‐based exercise program
Number of subjects: 60
Study: 33317422

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 39
Study: 32119742

Group type: EXPERIMENTAL
Intervention: Preventive Zinc Supplementation (PZ; 7 mg Zn/d)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Control (placebo powder)
Number of subjects: 512
Study: 32490642

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment with aspirin
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Blacks
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Chronic kidney disease (CKD)
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1247
Study: 32201572

Group type: EXPERIMENTAL
Intervention: Anesthesiology control tower (ACT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No intervention (standard of anesthesia care)
Number of subjects: 58
Study: 35719232

Group type: EXPERIMENTAL
Intervention: Fatigue intervention with dominant plantar flexors (two 100-s MVICs with 60-s recovery)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control intervention (rested for 260-s)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fatigue intervention
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Repeated MVICs after fatigue intervention
Number of subjects: 16
Study: 33784735

Group type: EXPERIMENTAL
Intervention: Aflibercept injections (2.0 mg)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 328
Study: 32242987

Group type: EXPERIMENTAL
Intervention: P. palmata (2 g/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 104
Study: 35313201

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (20 Hz) at 85% of the MT, 25 trains of 5 s duration, total of 2500 pulses/session, applied over the left DLPFC for five consecutive days per week, for two weeks
Number of subjects: 28
Study: 33534082

Group type: EXPERIMENTAL
Intervention: Nomogram prediction calculator for postoperative mortality
Number of subjects: 0
Study: 34332629

Group type: EXPERIMENTAL
Intervention: Prolonged exclusive human-milk diet devoid of bovine-milk-based food components
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group of term-born infants
Number of subjects: 200

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 200
Study: 32197493

Group type: EXPERIMENTAL
Intervention: iTIS (instrumented Trunk Impairment Scale) using the Valedo system
Number of subjects: 40

Group type: COMPARATOR
Intervention: TIS (Trunk Impairment Scale)
Number of subjects: 40
Study: 33909135

Group type: EXPERIMENTAL
Intervention: Induction therapy (chemoradiotherapy)
Number of subjects: 4279

Group type: EXPERIMENTAL
Intervention: Pneumonectomy
Number of subjects: 4279

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 4279

Group type: COMPARATOR
Intervention: Upfront surgery (Lobectomy)
Number of subjects: 4279

Group type: COMPARATOR
Intervention: Upfront surgery (Pneumonectomy)
Number of subjects: 4279

Group type: EXPERIMENTAL
Intervention: Lobectomy vs Pneumonectomy
Number of subjects: 4279
Study: 36457355

Group type: EXPERIMENTAL
Intervention: Intravesical Lactobacillus rhamnosus GG
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline bladder wash
Number of subjects: 120
Study: 32205243

Group type: EXPERIMENTAL
Intervention: Training series
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Validation series
Number of subjects: 600
Study: 35857290

Group type: EXPERIMENTAL
Intervention: Topical synthetic hypericin ointment, 0.25%, activated with visible light, applied to 3 index lesions twice weekly for 6 weeks (Cycle 1)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Topical synthetic hypericin ointment, 0.25%, activated with visible light, applied to index lesions for 6 weeks (Cycle 2)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Topical synthetic hypericin ointment, 0.25%, activated with visible light, applied to index and additional lesions for 6 weeks (Cycle 3)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo applied to 3 index lesions twice weekly for 6 weeks (Cycle 1)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Topical synthetic hypericin ointment, 0.25%, activated with visible light (all cycles)
Number of subjects: 169
Study: 32737388

Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW) in men
Number of subjects: 8278

Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW) in women
Number of subjects: 8278
Study: 34108180

Group type: EXPERIMENTAL
Intervention: Dabrafenib plus Trametinib
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: High B-cell signatures
Number of subjects: 146
Study: 34010952

Group type: EXPERIMENTAL
Intervention: Coherently disarrayed sequences
Number of subjects: 243

Group type: COMPARATOR
Intervention: Incoherently disarrayed sequences
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Gut feeling response
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Sure response
Number of subjects: 243
Study: 33843952

Group type: EXPERIMENTAL
Intervention: AD genetic risk score (AD-GRS)
Number of subjects: 0
Study: 36207203

Group type: EXPERIMENTAL
Intervention: Positive labels
Number of subjects: 3051

Group type: EXPERIMENTAL
Intervention: Negative labels
Number of subjects: 3051

Group type: EXPERIMENTAL
Intervention: Both positive and negative labels
Number of subjects: 3051

Group type: EXPERIMENTAL
Intervention: Only negative labels
Number of subjects: 3051

Group type: COMPARATOR
Intervention: Control (calorie)
Number of subjects: 3051
Study: 33541751

Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 304

Group type: COMPARATOR
Intervention: B-mode ultrasound with normal saline
Number of subjects: 304

Group type: COMPARATOR
Intervention: Empirical diagnosis
Number of subjects: 304

Group type: COMPARATOR
Intervention: Computed Tomography
Number of subjects: 304

Group type: COMPARATOR
Intervention: B-mode ultrasound
Number of subjects: 304
Study: 32544602

Group type: EXPERIMENTAL
Intervention: Concordant clinician (CC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Discordant clinician (DC)
Number of subjects: 66
Study: 36201360

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg
Number of subjects: 140
Study: 33559410

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine Surveillance (RS)
Number of subjects: 0
Study: 33136423

Group type: EXPERIMENTAL
Intervention: PRP T1D
Number of subjects: 264

Group type: COMPARATOR
Intervention: Education Intervention (EI)
Number of subjects: 264
Study: 36172298

Group type: EXPERIMENTAL
Intervention: Low volume PEG plus senna
Number of subjects: 382

Group type: COMPARATOR
Intervention: High volume PEG
Number of subjects: 382
Study: 33562774

Group type: EXPERIMENTAL
Intervention: Sentinel-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated data with varying intervals (12 and 35 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERS and Envisat results
Number of subjects: 0
Study: 34053249

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) plus traditional physical therapy program (TPTP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional physical therapy program (TPTP)
Number of subjects: 40
Study: 35236281

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)-based algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: No algorithm
Number of subjects: 0
Study: 32548638

Group type: EXPERIMENTAL
Intervention: GSSO ontology version 2
Number of subjects: 0
Study: 34996786

Group type: EXPERIMENTAL
Intervention: Physiotherapy blended with six online modules of pain education and behavioural activation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 0
Study: 33651414

Group type: EXPERIMENTAL
Intervention: Steroid treatment for Bell's palsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 0
Study: 32605059

Group type: EXPERIMENTAL
Intervention: Healthy Eating pattern
Number of subjects: 1919

Group type: EXPERIMENTAL
Intervention: Western Sweet and Beverages pattern
Number of subjects: 1919

Group type: EXPERIMENTAL
Intervention: Western Salty and Alcohol pattern
Number of subjects: 1919
Study: 35362666

Group type: EXPERIMENTAL
Intervention: Planned delivery
Number of subjects: 901

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 901
Study: 32651477

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 221

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 221
Study: 32251813

Group type: EXPERIMENTAL
Intervention: Transforaminal full endoscopic lumbar discectomy (FELD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open discectomy (OD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: FELD
Number of subjects: 50

Group type: COMPARATOR
Intervention: OD
Number of subjects: 50
Study: 36288584

Group type: EXPERIMENTAL
Intervention: QLB with IV dexamethasone (DEX1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: QLB with dexamethasone (DEX2)
Number of subjects: 105

Group type: COMPARATOR
Intervention: QLB alone (CONTROL)
Number of subjects: 105
Study: 34870067

Group type: EXPERIMENTAL
Intervention: Gym and PT
Number of subjects: 19

Group type: COMPARATOR
Intervention: Gym only
Number of subjects: 19
Study: 34648897

Group type: EXPERIMENTAL
Intervention: Individualized in-person advance care planning (ACP) sessions delivered by nurses or social workers with nephrology or palliative care experience.
Number of subjects: 254

Group type: COMPARATOR
Intervention: Enhanced control group received Make Your Wishes About You (MY WAY) education materials and encouragement to bring completed advance directives.
Number of subjects: 254
Study: 33371976

Group type: EXPERIMENTAL
Intervention: Information-Motivation-Behavioral Skills Model interventions
Number of subjects: 50
Study: 35618342

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 38443

Group type: COMPARATOR
Intervention: DPP-4 inhibitors
Number of subjects: 38443
Study: 32277800

Group type: EXPERIMENTAL
Intervention: Prolonged exposure treatment protocol for children and adolescents (PE‐A)
Number of subjects: 37
Study: 36453018

Group type: EXPERIMENTAL
Intervention: Computer-based manipulable pelvic bone model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online static images of the same model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulable model-based posttest
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental effort scores
Number of subjects: 0
Study: 32537711

Group type: COMPARATOR
Intervention: Continuation of oral antibiotics (standard arm)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Stoppage of antibiotics (experimental arm)
Number of subjects: 75
Study: 35777275

Group type: EXPERIMENTAL
Intervention: 324 mg of VTS‐Aspirin™ and 0.5 mg/kg of oral ketamine (AOK)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5 mg/kg of oral ketamine (OK)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (AOK and OK)
Number of subjects: 60
Study: 32553881

Group type: EXPERIMENTAL
Intervention: 3RPT/INH (rifapentine and isoniazid)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Observation (untreated)
Number of subjects: 513
Study: 32270632

Group type: EXPERIMENTAL
Intervention: Midnight-noon ebb-flow acupuncture combined with rehabilitation therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rehabilitation therapy (control group)
Number of subjects: 100
Study: 33208009

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 34034365

Group type: EXPERIMENTAL
Intervention: High-TSH group (target TSH levels between 2.0 and 7.99 μIU/mL)
Number of subjects: 2986

Group type: COMPARATOR
Intervention: Low-TSH group (target TSH levels between 0.3 and 1.99 μIU/mL)
Number of subjects: 2986

Group type: EXPERIMENTAL
Intervention: High-TSH group
Number of subjects: 2986

Group type: COMPARATOR
Intervention: Low-TSH group
Number of subjects: 2986
Study: 32033610

Group type: EXPERIMENTAL
Intervention: Luteal-phase ovarian stimulation (LPOS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Follicular phase ovarian stimulation (FPOS)
Number of subjects: 60
Study: 36402359

Group type: EXPERIMENTAL
Intervention: High-dose IMRT (59.4 Gy)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard-dose IMRT (50.4 Gy)
Number of subjects: 167